183 related articles for article (PubMed ID: 38030596)
21. Enhancer identification in mouse embryonic stem cells using integrative modeling of chromatin and genomic features.
Chen CY; Morris Q; Mitchell JA
BMC Genomics; 2012 Apr; 13():152. PubMed ID: 22537144
[TBL] [Abstract][Full Text] [Related]
22. Generation of onco-enhancer enhances chromosomal remodeling and accelerates tumorigenesis.
Chai P; Yu J; Jia R; Wen X; Ding T; Zhang X; Ni H; Jia R; Ge S; Zhang H; Fan X
Nucleic Acids Res; 2020 Dec; 48(21):12135-12150. PubMed ID: 33196849
[TBL] [Abstract][Full Text] [Related]
23. Histone Deacetylase HDAC8 Promotes Insulin Resistance and β-Catenin Activation in NAFLD-Associated Hepatocellular Carcinoma.
Tian Y; Wong VW; Wong GL; Yang W; Sun H; Shen J; Tong JH; Go MY; Cheung YS; Lai PB; Zhou M; Xu G; Huang TH; Yu J; To KF; Cheng AS; Chan HL
Cancer Res; 2015 Nov; 75(22):4803-16. PubMed ID: 26383163
[TBL] [Abstract][Full Text] [Related]
24. cAMP signaling increases histone deacetylase 8 expression via the Epac2-Rap1A-Akt pathway in H1299 lung cancer cells.
Park JY; Juhnn YS
Exp Mol Med; 2017 Feb; 49(2):e297. PubMed ID: 28232663
[TBL] [Abstract][Full Text] [Related]
25. HDAC8 Deacetylates HIF-1α and Enhances Its Protein Stability to Promote Tumor Growth and Migration in Melanoma.
Kim JY; Cho H; Yoo J; Kim GW; Jeon YH; Lee SW; Kwon SH
Cancers (Basel); 2023 Feb; 15(4):. PubMed ID: 36831463
[TBL] [Abstract][Full Text] [Related]
26. HDAC8 Inhibition Blocks SMC3 Deacetylation and Delays Cell Cycle Progression without Affecting Cohesin-dependent Transcription in MCF7 Cancer Cells.
Dasgupta T; Antony J; Braithwaite AW; Horsfield JA
J Biol Chem; 2016 Jun; 291(24):12761-12770. PubMed ID: 27072133
[TBL] [Abstract][Full Text] [Related]
27. Aryl hydrocarbon receptor regulates histone deacetylase 8 expression to repress tumor suppressive activity in hepatocellular carcinoma.
Wang LT; Chiou SS; Chai CY; Hsi E; Wang SN; Huang SK; Hsu SH
Oncotarget; 2017 Jan; 8(5):7489-7501. PubMed ID: 27283490
[TBL] [Abstract][Full Text] [Related]
28. HDAC8 overexpression in mesenchymal stromal cells from JAK2+ myeloproliferative neoplasms: a new therapeutic target?
Ramos TL; Sánchez-Abarca LI; Redondo A; Hernández-Hernández Á; Almeida AM; Puig N; Rodríguez C; Ortega R; Preciado S; Rico A; Muntión S; Porras JRG; Del Cañizo C; Sánchez-Guijo F
Oncotarget; 2017 Apr; 8(17):28187-28202. PubMed ID: 28390197
[TBL] [Abstract][Full Text] [Related]
29. Non-epigenetic function of HDAC8 in regulating breast cancer stem cells by maintaining Notch1 protein stability.
Chao MW; Chu PC; Chuang HC; Shen FH; Chou CC; Hsu EC; Himmel LE; Huang HL; Tu HJ; Kulp SK; Teng CM; Chen CS
Oncotarget; 2016 Jan; 7(2):1796-807. PubMed ID: 26625202
[TBL] [Abstract][Full Text] [Related]
30. HDAC8 as an emerging target in drug discovery with special emphasis on medicinal chemistry.
Rajaraman S; Balakrishnan R; Deshmukh D; Ganorkar A; Biswas S; Pulya S; Ghosh B
Future Med Chem; 2023 May; 15(10):885-908. PubMed ID: 37227732
[TBL] [Abstract][Full Text] [Related]
31. The EP300, KDM5A, KDM6A and KDM6B chromatin regulators cooperate with KLF4 in the transcriptional activation of POU5F1.
Wang WP; Tzeng TY; Wang JY; Lee DC; Lin YH; Wu PC; Chen YP; Chiu IM; Chi YH
PLoS One; 2012; 7(12):e52556. PubMed ID: 23272250
[TBL] [Abstract][Full Text] [Related]
32. Covalent inhibition of histone deacetylase 8 by 3,4-dihydro-2H-pyrimido[1,2-c][1,3]benzothiazin-6-imine.
Muth M; Jänsch N; Kopranovic A; Krämer A; Wössner N; Jung M; Kirschhöfer F; Brenner-Weiß G; Meyer-Almes FJ
Biochim Biophys Acta Gen Subj; 2019 Mar; 1863(3):577-585. PubMed ID: 30611847
[TBL] [Abstract][Full Text] [Related]
33. Exome sequencing identifies a novel EP300 frame shift mutation in a patient with features that overlap Cornelia de Lange syndrome.
Woods SA; Robinson HB; Kohler LJ; Agamanolis D; Sterbenz G; Khalifa M
Am J Med Genet A; 2014 Jan; 164A(1):251-8. PubMed ID: 24352918
[TBL] [Abstract][Full Text] [Related]
34. Histone deacetylase 8 suppresses osteogenic differentiation of bone marrow stromal cells by inhibiting histone H3K9 acetylation and RUNX2 activity.
Fu Y; Zhang P; Ge J; Cheng J; Dong W; Yuan H; Du Y; Yang M; Sun R; Jiang H
Int J Biochem Cell Biol; 2014 Sep; 54():68-77. PubMed ID: 25019367
[TBL] [Abstract][Full Text] [Related]
35. Role of Non-Coding Regulatory Elements in the Control of GR-Dependent Gene Expression.
Borczyk M; Zieba M; Korostyński M; Piechota M
Int J Mol Sci; 2021 Apr; 22(8):. PubMed ID: 33923915
[TBL] [Abstract][Full Text] [Related]
36. Negative regulation of histone deacetylase 8 activity by cyclic AMP-dependent protein kinase A.
Lee H; Rezai-Zadeh N; Seto E
Mol Cell Biol; 2004 Jan; 24(2):765-73. PubMed ID: 14701748
[TBL] [Abstract][Full Text] [Related]
37. Overexpressed HDAC8 in cervical cancer cells shows functional redundancy of tubulin deacetylation with HDAC6.
Vanaja GR; Ramulu HG; Kalle AM
Cell Commun Signal; 2018 May; 16(1):20. PubMed ID: 29716651
[TBL] [Abstract][Full Text] [Related]
38. Dynamic regulation of the human dopachrome tautomerase promoter by MITF, ER-alpha and chromatin remodelers during proliferation and senescence of human melanocytes.
Schwahn DJ; Timchenko NA; Shibahara S; Medrano EE
Pigment Cell Res; 2005 Jun; 18(3):203-13. PubMed ID: 15892717
[TBL] [Abstract][Full Text] [Related]
39. EP300 knockdown reduces cancer stem cell phenotype, tumor growth and metastasis in triple negative breast cancer.
Ring A; Kaur P; Lang JE
BMC Cancer; 2020 Nov; 20(1):1076. PubMed ID: 33167919
[TBL] [Abstract][Full Text] [Related]
40. Noncanonical EphA2 Signaling Is a Driver of Tumor-Endothelial Cell Interactions and Metastatic Dissemination in BRAF Inhibitor‒Resistant Melanoma.
Zhang C; Smalley I; Emmons MF; Sharma R; Izumi V; Messina J; Koomen JM; Pasquale EB; Forsyth PA; Smalley KSM
J Invest Dermatol; 2021 Apr; 141(4):840-851.e4. PubMed ID: 32890629
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]